Trials / Terminated
TerminatedNCT00240747
Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 27 Weeks – 16 Years
- Healthy volunteers
- Not accepted
Summary
Open-label, multicenter, multiple-dose, study of population pharmacokinetics of I.V. Synercid (7.5 mg/kg every 8 hours) in 75 pediatric patients. The purpose is to assess the population pharmacokinetics of Synercid in pediatric patients and to collect additional safety and efficacy data in pediatric patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Synercid |
Timeline
- Start date
- 2000-06-01
- Completion
- 2005-01-01
- First posted
- 2005-10-18
- Last updated
- 2012-05-25
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00240747. Inclusion in this directory is not an endorsement.